These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24335848)

  • 1. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
    Stovner LJ; Linde M; Gravdahl GB; Tronvik E; Aamodt AH; Sand T; Hagen K
    Cephalalgia; 2014 Jun; 34(7):523-32. PubMed ID: 24335848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.
    Tronvik E; Stovner LJ; Helde G; Sand T; Bovim G
    JAMA; 2003 Jan; 289(1):65-9. PubMed ID: 12503978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
    Hagen K; Brenner E; Linde M; Gravdahl GB; Tronvik EA; Engstrøm M; Sonnewald U; Helde G; Stovner LJ; Sand T
    Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
    Sjølie AK; Klein R; Porta M; Orchard T; Fuller J; Parving HH; Bilous R; Chaturvedi N;
    Lancet; 2008 Oct; 372(9647):1385-93. PubMed ID: 18823658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
    Chaturvedi N; Porta M; Klein R; Orchard T; Fuller J; Parving HH; Bilous R; Sjølie AK;
    Lancet; 2008 Oct; 372(9647):1394-402. PubMed ID: 18823656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
    Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
    Charles JA; Jotkowitz S; Byrd LH
    Headache; 2006 Mar; 46(3):503-7. PubMed ID: 16618270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Edvinsson L; Rapoport AM; Lipton RB; Spierings EL; Diener HC; Burstein R; Loupe PS; Ma Y; Yang R; Silberstein SD
    Lancet Neurol; 2015 Nov; 14(11):1091-100. PubMed ID: 26432181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
    Diener HC; Tfelt-Hansen P; Dahlöf C; Láinez MJ; Sandrini G; Wang SJ; Neto W; Vijapurkar U; Doyle A; Jacobs D;
    J Neurol; 2004 Aug; 251(8):943-50. PubMed ID: 15316798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
    Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J
    Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
    Loo LS; Ailani J; Schim J; Baygani S; Hundemer HP; Port M; Krege JH
    J Headache Pain; 2019 Jul; 20(1):84. PubMed ID: 31340760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial.
    Diener HC; Gendolla A; Feuersenger A; Evers S; Straube A; Schumacher H; Davidai G
    Cephalalgia; 2009 Sep; 29(9):921-7. PubMed ID: 19250283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
    Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS
    Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
    Chowdhury D; Bansal L; Duggal A; Datta D; Mundra A; Krishnan A; Koul A; Gupta A
    Cephalalgia; 2022 Apr; 42(4-5):396-408. PubMed ID: 34579560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
    Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.